Suppr超能文献

伴侣蛋白 SmgGDS-607 具有双重作用,既能激活又能抑制小分子 GTP 酶的法尼基化。

The chaperone SmgGDS-607 has a dual role, both activating and inhibiting farnesylation of small GTPases.

机构信息

Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan 48109.

Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109

出版信息

J Biol Chem. 2019 Aug 2;294(31):11793-11804. doi: 10.1074/jbc.RA119.007438. Epub 2019 Jun 13.

Abstract

Ras family small GTPases undergo prenylation (such as farnesylation) for proper localization to the plasma membrane, where they can initiate oncogenic signaling pathways. Small GTP-binding protein GDP-dissociation stimulator (SmgGDS) proteins are chaperones that bind and traffic small GTPases, although their exact cellular function is unknown. Initially, SmgGDS proteins were classified as guanine nucleotide exchange factors, but recent findings suggest that SmgGDS proteins also regulate prenylation of small GTPases in a substrate-selective manner. SmgGDS-607 recognizes the polybasic region and the CAA box of several small GTPases and inhibits prenylation by impeding their entry into the geranylgeranylation pathway. Here, using recombinant and purified enzymes for prenylation and protein-binding assays, we demonstrate that SmgGDS-607 differentially regulates farnesylation of several small GTPases. SmgGDS-607 inhibited farnesylation of some proteins, such as DiRas1, by sequestering the protein and limiting modification catalyzed by protein farnesyltransferase (FTase). We found that the competitive binding affinities of the small GTPase for SmgGDS-607 and FTase dictate the extent of this inhibition. Additionally, we discovered that SmgGDS-607 increases the rate of farnesylation of HRas by enhancing product release from FTase. Our work indicates that SmgGDS-607 binds to a broad range of small GTPases and does not require a PBR for recognition. Together, these results provide mechanistic insight into SmgGDS-607-mediated regulation of farnesylation of small GTPases and suggest that SmgGDS-607 has multiple modes of substrate recognition.

摘要

Ras 家族的小 GTP 酶经历 prenylation(如 farnesylation)以正确定位于质膜,在那里它们可以启动致癌信号通路。Small GTP-binding protein GDP-dissociation stimulator (SmgGDS) 蛋白是伴侣蛋白,可结合并运输小 GTP 酶,尽管其确切的细胞功能尚不清楚。最初,SmgGDS 蛋白被归类为鸟嘌呤核苷酸交换因子,但最近的发现表明,SmgGDS 蛋白还以底物选择性的方式调节小 GTP 酶的 prenylation。SmgGDS-607 识别几个小 GTP 酶的多碱性区域和 CAA 盒,并通过阻碍它们进入 geranylgeranylation 途径来抑制 prenylation。在这里,我们使用重组和纯化的 prenylation 和蛋白结合测定酶来证明 SmgGDS-607 差异调节几种小 GTP 酶的 farnesylation。SmgGDS-607 通过隔离蛋白并限制蛋白 farnesyltransferase (FTase) 催化的修饰来抑制一些蛋白的 farnesylation,如 DiRas1。我们发现小 GTPase 与 SmgGDS-607 和 FTase 的竞争结合亲和力决定了这种抑制的程度。此外,我们发现 SmgGDS-607 通过增强从 FTase 释放产物来增加 HRas 的 farnesylation 速率。我们的工作表明 SmgGDS-607 与广泛的小 GTPase 结合,并且不需要 PBR 进行识别。总之,这些结果为 SmgGDS-607 介导的小 GTP 酶 farnesylation 调节提供了机制见解,并表明 SmgGDS-607 具有多种底物识别模式。

相似文献

1
The chaperone SmgGDS-607 has a dual role, both activating and inhibiting farnesylation of small GTPases.
J Biol Chem. 2019 Aug 2;294(31):11793-11804. doi: 10.1074/jbc.RA119.007438. Epub 2019 Jun 13.
4
Splice variants of SmgGDS control small GTPase prenylation and membrane localization.
J Biol Chem. 2010 Nov 12;285(46):35255-66. doi: 10.1074/jbc.M110.129916. Epub 2010 Aug 13.
5
SmgGDS-607 Regulation of RhoA GTPase Prenylation Is Nucleotide-Dependent.
Biochemistry. 2018 Jul 24;57(29):4289-4298. doi: 10.1021/acs.biochem.8b00567. Epub 2018 Jul 10.
6
SmgGDS displays differential binding and exchange activity towards different Ras isoforms.
Oncogene. 2002 Apr 4;21(15):2425-32. doi: 10.1038/sj.onc.1205306.
8
Splice switching an oncogenic ratio of SmgGDS isoforms as a strategy to diminish malignancy.
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3627-3636. doi: 10.1073/pnas.1914153117. Epub 2020 Feb 4.
9
GEF mechanism revealed by the structure of SmgGDS-558 and farnesylated RhoA complex and its implication for a chaperone mechanism.
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9563-9568. doi: 10.1073/pnas.1804740115. Epub 2018 Sep 6.

引用本文的文献

1
DIRAS1 Drives Oxaliplatin Resistance in Colorectal Cancer via PHB1-Mediated Mitochondrial Homeostasis.
Biology (Basel). 2025 Jul 5;14(7):819. doi: 10.3390/biology14070819.
2
Protein prenylation in islet β-cell function in health and metabolic stress.
Biochem Pharmacol. 2025 Aug;238:116994. doi: 10.1016/j.bcp.2025.116994. Epub 2025 May 21.
4
Novel regulatory roles of small G protein GDP dissociation stimulator (smgGDS) in insulin secretion from pancreatic β-cells.
Mol Cell Endocrinol. 2024 Jan 15;580:112104. doi: 10.1016/j.mce.2023.112104. Epub 2023 Oct 30.
5
Structural and biophysical properties of farnesylated KRas interacting with the chaperone SmgGDS-558.
Biophys J. 2022 Oct 4;121(19):3684-3697. doi: 10.1016/j.bpj.2022.05.028. Epub 2022 May 25.
6
Post-translational modification of RAS proteins.
Curr Opin Struct Biol. 2021 Dec;71:180-192. doi: 10.1016/j.sbi.2021.06.015. Epub 2021 Aug 6.
7
SmgGDS: An Emerging Master Regulator of Prenylation and Trafficking by Small GTPases in the Ras and Rho Families.
Front Mol Biosci. 2021 Jun 16;8:685135. doi: 10.3389/fmolb.2021.685135. eCollection 2021.
9
Post-translational modification of KRAS: potential targets for cancer therapy.
Acta Pharmacol Sin. 2021 Aug;42(8):1201-1211. doi: 10.1038/s41401-020-00542-y. Epub 2020 Oct 21.
10
Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities.
Cancer Discov. 2020 Dec;10(12):1950-1967. doi: 10.1158/2159-8290.CD-19-1274. Epub 2020 Jul 29.

本文引用的文献

1
SmgGDS-607 Regulation of RhoA GTPase Prenylation Is Nucleotide-Dependent.
Biochemistry. 2018 Jul 24;57(29):4289-4298. doi: 10.1021/acs.biochem.8b00567. Epub 2018 Jul 10.
3
Differences in the Phosphorylation-Dependent Regulation of Prenylation of Rap1A and Rap1B.
J Mol Biol. 2016 Dec 4;428(24 Pt B):4929-4945. doi: 10.1016/j.jmb.2016.10.016. Epub 2016 Oct 17.
5
Di-Ras2 Protein Forms a Complex with SmgGDS Protein in Brain Cytosol in Order to Be in a Low Affinity State for Guanine Nucleotides.
J Biol Chem. 2015 Aug 14;290(33):20245-56. doi: 10.1074/jbc.M115.637769. Epub 2015 Jul 6.
6
Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.
Medchemcomm. 2013 Mar;4(3):476-492. doi: 10.1039/C2MD20299A.
7
Targeting RAS-ERK signalling in cancer: promises and challenges.
Nat Rev Drug Discov. 2014 Dec;13(12):928-42. doi: 10.1038/nrd4281.
8
Drugging the undruggable RAS: Mission possible?
Nat Rev Drug Discov. 2014 Nov;13(11):828-51. doi: 10.1038/nrd4389. Epub 2014 Oct 17.
10
A new signaling paradigm to control the prenylation and trafficking of small GTPases.
Cell Cycle. 2013;12(18):2933-4. doi: 10.4161/cc.26230. Epub 2013 Aug 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验